Dr. Al-Mayahie has completed her Ph.D. at the age of 37 years from University of Baghdad. She has published more than 14 papers in reputed journals.

Dr. Al-Mayahie is interested in molecular biology of pathogenic bacteria: pathogenesis, virulence and antimicrobial resistance.

Prof. Robert Schiestl received his PhD from the University of Vienna, Austria at the age of 23. He did postdoctoral work in Edmonton, Alberta, Rochester NY and Chapel Hill, NC. He was professor at Harvard with the age of 31 where he stayed for 10 years. Since 19 years he is Professor at UCLA.

.

Dr. Raafat have completed his PhD from Mansoura University and postdoctoral Studies from Mansoura University Schools of Science and Medicine.

Forensic Chemistry and Toxicology, water pollution and medical analysis

MBBS, MD (CLINICAL PATHOLOGY) 34 Years of experience, now working as head of PATHOLOGY in AL JEDANI GROUP HOSPITAL & MEDICAL COLLEGE IN JEDDAH

will be updated soon..!

For 25 years, Ivan Brandslund has been a laboratory director and chief physician at Vejle Hospital and at the same time held a lecturer in teaching and research at the Faculty of Health Sciences, University of Southern Denmark (SDU). He is the author of over 150 scientific articles on the development and application of methods for rational diagnostics and control of human disease treatment. In recent years, especially in blood thinning treatment, cancer and diabetes. Ivan Brandslund is a specialist in clinical biochemistry at OUH and holds a scientific career from SDU and as an international research fellow at Dept. Of Public Health, USA, from which he was taken to the Laboratory at Vejle Hospital in 1985. He was the main character behind the building of the Laboratory Center at Vejle Hospital, which houses five medical diagnostic specialties, with a large and growing scientific production. His future research efforts will focus on biochemical nanotechnology methods that will enable measurement of single cell protein, RNA and DNA for diagnostic and individual treatment management in cancer and diabetes based on the isolation of cancer cells in a blood sample and on blood indicator proteins, in collaboration with oncologists And diabetes doctors in the Region of Southern Denmark. Ivan Brandslund is a partner in the National Diabetes Type 2 project, DD2, with analysis / biobank functions, and groups in cancer research, among others. The Danish National Board of Health on a new method for screening for cervical cancer.

Clinical Professor, Biochemistry and Immunology

Dr. Swenberg’s long, successful research career focused on chemical carcinogenesis and toxicology, with an emphasis on studying the role of DNA damage and repair in carcinogenesis, developing highly sensitive assay methods for DNA and protein adduct research and improving the scientific basis of risk assessment. He makes extensive use of mass spectroscopy for biomarker studies. After a successful industrial and research institute career, he joined UNC-Chapel Hill as a professor in the Department of Environmental Sciences and Engineering. In addition to his Department of Nutrition appointment, he is also a professor in the Department of Pathology and Laboratory Medicine and is the Director of Curriculum in Toxicology. He is affiliated with the Department of Nutrition as a trainer on the Department of Nutrition’s NIH Training Grant. His work on oxidant damage is of great interest to the Department and he contributes research supervision and instruction to Nutrition graduate students. He is a member of numerous prestigious toxicology and pathology societies and serves on several science and editorial advisory boards.

Chemical carcinogenesis and toxicology, Role of DNA damage and repair in carcinogenesis, Development of highly sensitive assay methods for DNA and protein adduct research

Dr. Claudio Sorio is Associate Professor of General Pathology. He is the founder and serves as Director of the Departmental Laboratory of Translational Research In Cystic Fibrosis of the Department of Medicine of the University of Verona. Study of Biomarkers for Cancer and Cystic Fibrosis are the main field of interests, with a specific focus on the role of Protein Tyrosine Phosphatase Gamma (PTPRG) in health and disease, that he discoverd having a role as dendritic cell biomarker and as tumor suppressor gene in chronic myeloid leukemia. In the field of cystic fibrosis since 2009 he promoted the study of the role of leukocytes, especially monocytes, in the disease and as a tool to better understand its pathogenesis and be exploited as disease biomarker. He has been leading and actively participating to multiple research projects in leukemia and Cystic Fibrosis. He authored 74 original publications in international journals and is the single major contributor in the field of PTPRG characterization. He has been serving as an editorial board member of various reputed journals. He is member of many scientific societies and has participated in relevant national and international research projects.

Biomarkers of disease

Kadri Altundag was a professor of Medical Oncology. His main interest area is breast cancer. Kadri Altundag had been at MD AndersonCancer Center, Texas, the USA between 2004-2006 as visiting scientist and worked there at Breast MedicalOncology Department. Elsevier-Scopus honoured him to receive an award as one of the top-ten scientist

Breast cancer

Dr. Ian Martins is a Reveiwer for international journals. Chief Editor for International Journal of Diabetes Research (2014-2017), Research and Reviews: Neuroscience (2016-2017), Journal of Diabetes and Clinical Studies. BIT Member (BIT Congress. Inc) with H-index of 43, (ResearchGate STATs (23), Mendeley STATS (20). Scientist for Science Advisory Board (USA)/Academic with Academia.edu. Citations > 3000. ResearchGate’s analysis available on google, Tweet, Facebook, Lindekin under Ian James Martins’ name > 96% of the international SCIENTISTS. Lifetime Membership by International Agency for Standards and Ratings as Fellow for Diabetes, Medical Science (Nutrition). Conferred with the RICHARD KUHN RESEARCH AWARD-2015 ENDOCRINOLOGY AND METABOLISM.

Early diagnosis of global organ disease involve genomic, lipidomic and proteomic biomarker tests that may diagnose early neuron dysfunction with the prevention of various organ diseases. Diet and nutrition are closely linked to accelerated aging and may allow biomarker tests to provide adequate information with relevance to the immune system dysfunction and the severity of chronic diseases.

For 25 years, Ivan Brandslund has been a laboratory director and chief physician at Vejle Hospital and at the same time held a lecturer in teaching and research at the Faculty of Health Sciences, University of Southern Denmark (SDU). He is the author of over 150 scientific articles on the development and application of methods for rational diagnostics and control of human disease treatment. In recent years, especially in blood thinning treatment, cancer and diabetes. Ivan Brandslund is a specialist in clinical biochemistry at OUH and holds a scientific career from SDU and as an international research fellow at Dept. Of Public Health, USA, from which he was taken to the Laboratory at Vejle Hospital in 1985. He was the main character behind the building of the Laboratory Center at Vejle Hospital, which houses five medical diagnostic specialties, with a large and growing scientific production. His future research efforts will focus on biochemical nanotechnology methods that will enable measurement of single cell protein, RNA and DNA for diagnostic and individual treatment management in cancer and diabetes based on the isolation of cancer cells in a blood sample and on blood indicator proteins, in collaboration with oncologists And diabetes doctors in the Region of Southern Denmark. Ivan Brandslund is a partner in the National Diabetes Type 2 project, DD2, with analysis / biobank functions, and groups in cancer research, among others. The Danish National Board of Health on a new method for screening for cervical cancer.

.

Dr. Swenberg’s long, successful research career focused on chemical carcinogenesis and toxicology, with an emphasis on studying the role of DNA damage and repair in carcinogenesis, developing highly sensitive assay methods for DNA and protein adduct research and improving the scientific basis of risk assessment. He makes extensive use of mass spectroscopy for biomarker studies. After a successful industrial and research institute career, he joined UNC-Chapel Hill as a professor in the Department of Environmental Sciences and Engineering. In addition to his Department of Nutrition appointment, he is also a professor in the Department of Pathology and Laboratory Medicine and is the Director of Curriculum in Toxicology. He is affiliated with the Department of Nutrition as a trainer on the Department of Nutrition’s NIH Training Grant. His work on oxidant damage is of great interest to the Department and he contributes research supervision and instruction to Nutrition graduate students. He is a member of numerous prestigious toxicology and pathology societies and serves on several science and editorial advisory boards.

Chemical carcinogenesis and toxicology, Role of DNA damage and repair in carcinogenesis, Development of highly sensitive assay methods for DNA and protein adduct research

Prof. Dr. Alireza Heidari, Ph.D., D.Sc. is a Full Professor and Academic Tenure of Chemistry at California South University (CSU), Irvine, California, USA. He has got his Ph.D. and D.Sc. degrees from California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management, Oncology, Human Cancer Tissues and Synchrotron Radiation from Monash University, Melbourne, Victoria, Australia and also in Nanochemistry and Modern Molecular Electronic–Structure Computations Theory from California South University (CSU), Irvine, California, USA. His research interests include Biophysical Chemistry, Biomolecular Spectroscopy, Quantum Chemistry, Nanochemistry, Modern Electronic Structure Computations, Theoretical Chemistry, Mathematical Chemistry, Computational Chemistry, Vibrational Spectroscopy, Molecular Modelling, Ab initio & Density Functional Methods, Molecular Structure, Biochemistry, Molecular Simulation, Pharmaceutical Chemistry, Medicinal Chemistry, Oncology, Synchrotron Radiation, LASER, Anti–Cancer Nano Drugs, Nano Drugs Delivery, ATR–FTIR Spectroscopy, Raman Spectroscopy, Intelligent Molecules, Molecular Dynamics, Biosensors, Biomarkers, Molecular Diagnostics, Numerical Chemistry, Nucleic Acids, DNA/RNA Monitoring, DNA/RNA Hypermethylation, Human Cancer Tissues, Human Cancer Cells, Tumors, Cancer Tissues, Cancer Cells, etc. He has participated at more than one hundred fifty reputed international conferences, seminars, congresses, symposiums and forums around the world as yet. Also, he possesses many published articles in Science Citation Index (SCI)/International Scientific Indexing (ISI) Journals. It should be noted that he has visited many universities or scientific and academic research institutes in different countries such as United States, United Kingdom, Canada, Australia, Scotland, Ireland, Netherlands, Belgium, Denmark, Greece, Russia, Estonia, Turkey, France, Swiss, Germany, Sweden, Italy, Austria, Hungary, Poland, Spain, Portugal, Mexico, Japan, Malaysia, Thailand, Taiwan, South Korea, China, India, Qatar, United Arab Emirates, etc. as research fellow, sabbatical and volunteer researcher or visitor and so on heretofore. He has a history of several years of teaching for college students and various disciplines and trends in different universities. Moreover, he has been a senior advisor in various industry and factories. He is expert in many computer programs and programming languages. Hitherto, he has authored more than twenty books and book chapters in different fields of Chemistry. Syne, he has been awarded more than seven hundreds reputed international awards, prizes, scholarships and honors. Heretofore, he has multiple editorial duties in many reputed international journals, books and publishers. Hitherward, he is a member of more than two hundreds reputed international academic–scientific–research institutes around the world. In addition, he is member of the Nobel committee for Chemistry. It should be noted that he is currently the President of American International Standards Institute (AISI), Irvine, California, USA and also Director of the BioSpectroscopy Core Research Laboratory at California South University (CSU), Irvine, California, USA.

Biophysical Chemistry, Biomolecular Spectroscopy, Quantum Chemistry, Nanochemistry, Modern Electronic Structure, Computations, Theoretical Chemistry, Mathematical Chemistry, Computational Chemistry, Vibrational Spectroscopy, Molecular Modelling, Ab initio & Density Functional Methods, Molecular Structure, Biochemistry, Molecular Simulation, Pharmaceutical Chemistry, Medicinal Chemistry, Oncology, Synchrotron Radiation, LASER, Anti–Cancer Nano Drugs, Nano Drugs Delivery, ATR–FTIR Spectroscopy, Raman Spectroscopy, Intelligent Molecules, Molecular Dynamics, Biosensors, Biomarkers, Molecular Diagnostics, Numerical Chemistry, Nucleic Acids, DNA/RNA Monitoring, DNA/RNA Hypermethylation, Human Cancer Tissues, Human Cancer Cells, Tumors, Cancer Tissues, Cancer Cells

Roberto Menicagli has completed his Ph.D. at the age of 25 years from Milan University. Postdoctoral studies in biochemistry and molecular genetics, the faculty of biology at Milan University. In this university, he has been professor to Contract, and became responsible for the Project ENEA-CNR for Environmental Pollution and Biomarkers ,after thirty years ,in industrial biochemistry experience ,as Senior Research in ENIRESEARCH, the most important group of the research in Italy, now, for five years, he is the director of Roma Biomed Research Lab a Private Medical Service Organization. He has published, in this field, more than 20 papers, in many journals, some with Impact Factor, he is also the principal author of 4 international patents, in the field of the environment and biomarkers, and has been serving as an editorial board member of some magazines, concerning the medical sciences.

Medicinal Chemistry, industrial biochemistry, biochemistry and molecular genetics

Dr. Claudio Sorio is Associate Professor of General Pathology. He is the founder and serves as Director of the Departmental Laboratory of Translational Research In Cystic Fibrosis of the Department of Medicine of the University of Verona. Study of Biomarkers for Cancer and Cystic Fibrosis are the main field of interests, with a specific focus on the role of Protein Tyrosine Phosphatase Gamma (PTPRG) in health and disease, that he discoverd having a role as dendritic cell biomarker and as tumor suppressor gene in chronic myeloid leukemia. In the field of cystic fibrosis since 2009 he promoted the study of the role of leukocytes, especially monocytes, in the disease and as a tool to better understand its pathogenesis and be exploited as disease biomarker. He has been leading and actively participating to multiple research projects in leukemia and Cystic Fibrosis. He authored 74 original publications in international journals and is the single major contributor in the field of PTPRG characterization. He has been serving as an editorial board member of various reputed journals. He is member of many scientific societies and has participated in relevant national and international research projects.

Biomarkers of disease

Dr. Nickolas is an anatomic pathologist with interest in breast surgical pathology. In addition he is interested in evidence-based medicine in respect to efficiency of medical interventions and accuracy of diagnostic procedures.Currently he is a Clinical Associate Professor at UBC and Anatomical Pathologist at St.Paul’s Hospital. He is awarded with UICC Fellowship for junior investigators, 2007-2008, Government of Newfoundland and Labrador, Travelling Fellowship, 2007-2008, and Canadian Association of Pathologists, Junior Scientist Award, 2006. He has experience teaching a wide spectrum of topics in pathology in university settings for small and large classes, residency training, medical and non-medical students, graduate, postgraduate and undergraduate levels. He has published more than 50 research papers.

Diagnostic Surgical pathology of breast disease, evidence-based practice of pathology. I am interested in clinical research evidence synthesis through critical appraisal of medical literature; diagnostic theory based on Bayesian reasoning and nature and sources of bias in clinical research.

Dr. Omyma A. Abd-Allah is a Professor of Organic Chemistry in Department of Chemistry, Faculty of Science, Sohag University, Egypt since 2017.She awarded her M.Sc. in Organic Chemistry (1989) from Assiut University. She awarded her Ph.D. in Organic Chemistry (1995) from South Valley University. She has published more than 40 research papers in the areas of Organometallic Chemistry, Medicinal Chemistry and Organic Chemistry. She contributed in many international conferences, seminars and symposiums. Also, She has a history of several years of teaching for college students and various disciplines and trends in different universities.

Organic Chemistry, Medicinal chemistry and Organometallic Chemistry

Dr. Lopez-Ruiz has completed his Ph.D. from Valencia University and postdoctoral studies from CEU Cardinal Herrera Health Sciences Faculty. She obtained her doctorate in Medicine with the doctoral thesis on “Analysis of the use of medication in the paediatric population that visit accident and emergency department” with summa cum laude. She has achieved the qualification of “University Expert in Neonatology” from the Catholic University of Valencia and “Master’s Degree in Neonatology (from de SENeo -Neonatology Spanish Society-)”. She is Medicine Degree Coordinator in CEU Cardenal Herrera University since 2015. She is the director of the “Master’s degree in Neonatal Intensive care and Neonatal Nursing”. She has attended to International Congresses of Pediatrics as a keynote speaker and she has been part of the Organizing Committee member for the 12th International Conference on Pediatric Pathology and Laboratory Medicine, and she has published in reputed international journals.

Pediatrics, Neonatology, Human Anatomy, Pharmacology

Idress Hamad Attitalla is working as Visiting Scientist in Department of Biological Sciences, Universiti Sains Malaysia, Palau Pinang, Malaysia since 2010. In 1998, he was appointed as Lecturer Assistant at the Department of Biological Sciences, Faculty of Science, Omar Al-Mukhtar University, El-Beida, Libya. In 2004, he was appointed as Lecturer at the Department of Biological Sciences, Faculty of Science, Omar Al-Mukhtar University, El-Beida, Libya. In 2007, he was appointed as Assistant Professor at the Department of Biological Sciences, Faculty of Science, Omar Al-Mukhtar University, El-Beida, Libya. In 2009, he was appointed as Associate Professor at the Department of Biological Sciences, Faculty of Science, Omar Al-Mukhtar University, El-Beida, Libya. In 2010, he was appointed as Visiting Scientist at the Department of Biological Sciences, Universiti Sains Malaysia, Palau Pinang, Malaysia. Idress Hamad Attitalla received his B.Sc. in Biology in 1992 at Department of Biological Sciences, Faculty of Science, Omar Al-Mukhtar University, El-Beida, Libya. He got M.Sc. in Biology in 1998 from Department of Plant Pathology and Bio-control Unit, Uppsala University, Uppsala, Sweden. Dr. Idress Hamad Attitalla obtained Ph.D. from Department of Molecular Evolution, Faculty of Science and Technology, Uppsala University, Uppsala, Sweden in 2004 in Molecular Evolution.

Plant Pathology, Plant Microbiology, Molecular Evolution,Soil Sciences, Algal Physiology, Plant Immunization, Phylogenetic.

He is a Consultant Physician and Clinical Pharmacologist at National Ayurveda Teaching Hospital, Sri Lanka and Head of the Department of Ayurveda Pharmacology and Pharmaceutics Institute of Indigenous Medicine, University of Colombo, Sri Lanka. He has delivered many guest lectures and keynote speeches. Has presented and published many papers at local and international conferences and journals in areas of Pharmacology, Toxicology, Immune medicine, Traditional medicine, Ayurveda, Pharmacovigilance, Bio transformation technologies, Bio medical-clinical ethics and Medical education. Won awards for research presentations both internationally and locally for scientific publications. Received several research grants and developed a research Unit for Ayurveda products to conduct experimental studies and clinical trials in the Institute of Indigenous Medicine, University of Colombo. Supervising research of Special Degrees /Post Graduate Diploma /MSc/MD(Ayu)/MPhil/PhD readers registered at Faculty of Graduate Studies in University of Colombo, University of Sri Jayewardenepura, University of Kelaniya, University of Peradeniya, Kothalawela Defence University, Sabaragamuwa University, Institute of Chemistry and students in Institute of Indigenous Medicine, University of Colombo. Serve as a reviewer and Editorial board member of peer review International journals. Currently collaboratively conducting research works with Federation University in Australia on projects that aims to validate Mobile Phone App with Ayurveda medicine concepts (Prakriti/ Body constitution) and architecture for Ayurvedic Electronic Health Records. Held the post of Head of Department of Allied Sciences, and currently hold Head of the Department of Ayurveda Pharmacology and Pharmaceutics.

Clinical trials, Phytomedicine , Traditional medicine , Quality assurance and standardization of Pharmaceuticals, Rational use of medicines, Pharmacovigilance and Adverse drug reactions, Arthritis, Cancer, Diabetes and other immune diseases, Medical education , Bio medical-clinical ethics, Bio-transformation technologies , Intellectual Property Rights (IPRs) development

Dr. Petr Starostik is Associate Professor of Pathology and serves as Director of Molecular Pathology in the Department of Pathology, Immunology, and Laboratory Medicine of the College of Medicine at the University of Florida in Gainesville, FL. Over the years, he directed several molecular diagnostics laboratories, both in the U.S. and abroad. Development of molecular diagnostic tests is his specialty as evidenced by his publications and the multitude of laboratory-developed tests performed in laboratories he directed. Besides clinical work, he also pursues basic research focusing on the role of FLT3 ITD in acute leukemia.

Molecular Pathology